Literature DB >> 32444389

Requirement of Complement C6 for Intact Innate Immune Responses in Mice.

Fatemeh Fattahi1,2, Jamison J Grailer2, Michella Parlett2, Hope Lu2, Elizabeth A Malan2, Elizabeth Abe2, Mark W Russell3, Lynn M Frydrych4, Matthew J Delano4, Firas S Zetoune2, Peter A Ward5.   

Abstract

Over the first days of polymicrobial sepsis, there is robust activation of the innate immune system, causing the appearance of proinflammatory cytokines and chemokines, along with the appearance of extracellular histones, which are highly proinflammatory and prothrombotic. In the current study, we studied different innate immune responses in mice with knockout (KO) of complement protein 6 (C6). Polymorphonuclear neutrophils (PMNs) from these KO mice had defective innate immune responses, including defective expression of surface adhesion molecules, generation of superoxide anion, and appearance of reactive oxygen species and histone release after activation of PMNs, along with defective phagocytosis. In addition, in C6-/- mice, the NLRP3 inflammasome was defective both in PMNs and in macrophages. When these KO mice were subjected to polymicrobial sepsis, their survival was improved, associated with reduced levels in the plasma of proinflammatory cytokines and chemokines and lower levels of histones in plasma. In addition, sepsis-induced cardiac dysfunction was attenuated in these KO mice. In a model of acute lung injury induced by LPS, C6-/- mice showed reduced PMN buildup and less lung epithelial/endothelial cell dysfunction (edema and hemorrhage). These data indicate that C6-/- mice have reduced innate immune responses that result in less organ injury and improved survival after polymicrobial sepsis.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32444389     DOI: 10.4049/jimmunol.1900801

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement.

Authors:  Lisa A Lewis; Sunita Gulati; Wioleta M Zelek; B Paul Morgan; Wen-Chao Song; Bo Zheng; Nancy Nowak; Rosane B DeOliveira; Bryan Sanchez; Leandro DeSouza Silva; Janine Schuurman; Frank Beurskens; Sanjay Ram; Peter A Rice
Journal:  J Infect Dis       Date:  2022-05-16       Impact factor: 7.759

2.  Helicid Improves Lipopolysaccharide-Induced Apoptosis of C6 Cells by Regulating SH2D5 DNA Methylation via the CytC/Caspase9/Caspase3 Signaling Pathway.

Authors:  Yuan Zhang; Mei Wang; Xiaotong Zhang; Zhenyi Jiang; Yuanxiang Zhang; Xiangjun Fu; Yanna Li; Danping Cao; Jun Han; Jiucui Tong
Journal:  Contrast Media Mol Imaging       Date:  2022-01-31       Impact factor: 3.161

3.  Accumulation of γδ T cells in visceral fat with aging promotes chronic inflammation.

Authors:  Maria E C Bruno; Sujata Mukherjee; Whitney L Powell; Stephanie F Mori; Franklyn K Wallace; Beverly K Balasuriya; Leon C Su; Arnold J Stromberg; Donald A Cohen; Marlene E Starr
Journal:  Geroscience       Date:  2022-04-28       Impact factor: 7.581

4.  Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels.

Authors:  Xiaobo Liu; Yuanyuan Wang; Alexander T Bauer; Michael Kirschfink; Peipei Ding; Christoffer Gebhardt; Lubor Borsig; Thomas Tüting; Thomas Renné; Karsten Häffner; Weiguo Hu; Stefan W Schneider; Christian Gorzelanny
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-12       Impact factor: 12.779

5.  Wnt-Signaling Inhibitor Wnt-C59 Suppresses the Cytokine Upregulation in Multiple Organs of Lipopolysaccharide-Induced Endotoxemic Mice via Reducing the Interaction between β-Catenin and NF-κB.

Authors:  Jaewoong Jang; Jaewon Song; Inae Sim; Young V Kwon; Yoosik Yoon
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

6.  Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae.

Authors:  Jutamas Shaughnessy; Y Tran; Bo Zheng; Rosane B DeOliveira; Sunita Gulati; Wen-Chao Song; James M Maclean; Keith L Wycoff; Sanjay Ram
Journal:  Front Immunol       Date:  2020-10-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.